## **Core Concept**
Dopamine is a catecholamine used in the management of acute congestive heart failure (CHF) and cardiogenic shock. It acts on various dopamine receptors and adrenergic receptors, producing dose-dependent effects. The primary receptors involved are dopamine D1, D2, α1, α2, and β1-adrenergic receptors.

## **Why the Correct Answer is Right**
At low doses, dopamine primarily acts on dopamine D1 and D2 receptors, causing vasodilation of renal and mesenteric blood vessels. At moderate doses, it acts on β1-adrenergic receptors, increasing heart rate and contractility. At high doses, it acts on α1-adrenergic receptors, causing vasoconstriction. Dopamine does not significantly act on **β2-adrenergic receptors** in the context of its primary uses in acute CHF; its effects are mainly through β1 receptors for cardiac augmentation and α1 receptors for vasoconstriction at higher doses.

## **Why Each Wrong Option is Incorrect**
- **Option A:** Dopamine does act on α1 receptors, especially at higher doses, causing vasoconstriction which can help in maintaining blood pressure in acute CHF or cardiogenic shock.
- **Option B:** Dopamine acts on D1 receptors, particularly at low doses, which helps in increasing renal blood flow.
- **Option C:** Dopamine acts on β1-adrenergic receptors, increasing cardiac contractility and heart rate, which is beneficial in acute CHF.

## **Clinical Pearl / High-Yield Fact**
A key clinical point to remember is that dopamine's effect on the heart (increased contractility) and blood vessels (vasoconstriction at high doses) makes it a valuable agent in acute CHF and cardiogenic shock. However, its use requires careful monitoring of blood pressure and organ perfusion.

## **Correct Answer:** D. β2 receptors.